Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

BLOCK LISTING SIX MONTHLY RETURN

20 Jun 2019 12:05

RNS Number : 9198C
Premier Veterinary Group PLC
20 June 2019
 

BLOCK LISTING SIX MONTHLY RETURN

 

Date: 20 June 2019

 

Name of applicant:

Premier Veterinary Group plc (formerly Ark Therapeutics Group plc)

 

Name of scheme:

2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan

 

Period of return:

From:

21/12/2018

To:

20/06/2019

Balance of unallotted securities under scheme(s) from previous return:

369,035 ordinary shares of 10 pence each

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

369,035 ordinary shares of 10 pence each

 

 

Name of applicant:

Premier Veterinary Group plc (formerly Ark Therapeutics Group plc)

 

Name of scheme:

2014 Ark Therapeutics Group plc Unapproved Share Option Plan

 

Period of return:

From:

21/12/2018

To:

20/06/2019

Balance of unallotted securities under scheme(s) from previous return:

30,000 ordinary shares of 10 pence each

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

30,000 ordinary shares of 10 pence each

 

 

Name of contact:

Andy Paull, CFO

Telephone number of contact:

0117 370 0300

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRFMMBTMBMTBIL

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS